October 29, 2025

FDA Pushes Faster, Cheaper Route for Biosimilar Approval

The FDA released new draft guidance to streamline biosimilar development.

Conexiant

October 29, 2025

H-1B Visa Changes: Who Pays the Price?

New fee structure could hit hardest where physicians are needed most.

Conexiant

October 23, 2025

Chest Pain & Shock After a Tuna Sandwich: What’s Your Diagnosis?

A 30-year-old man with no prior medical history developed cardiogenic shock shortly after eating a tuna sandwich. He experienced central, burning chest pain, diaphoresis, and generalized pruritus. His pain worsened with breathing and did not respond to nitroglycerin.

Conexiant

October 16, 2025

HHS Memo: Fringe Finds a Footing

From wheat fields to Washington: a decades-old fear about skies and 'sprays' rises again, colliding with science, social media, and the machinery of federal policymaking.

KFF Health News

October 14, 2025

Rare HeartMate 6 LVAD Saves Patient with Heart Failure After Chemotherapy

When an adverse reaction to chemotherapy sent a patient into heart failure, it took state-of-the-art treatment from an advanced cardiovascular team to save him in time.

Keck Medicine of USC

October 14, 2025

What Happened at Meeting on the Mesa 2025?

This year’s Meeting on the Mesa showed that cell and gene therapy is no longer defined by hype, but by hard work– from digital manufacturing to creative funding models and policy alignment.

The Medicine Maker

October 10, 2025

Adolescent and Adult VTE After Arthroscopy Compared in Study

Lower venous thromboembolism risk is shown in adolescents than adults after knee arthroscopy, but comorbidities like diabetes and obesity raise risk.

Conexiant

October 07, 2025

FDA Announces New Development in Lung Care

The FDA has approved the first treatment in more than a decade for idiopathic pulmonary fibrosis.

Conexiant

October 07, 2025

Sotatercept Reduced Clinical Worsening in PAH

Kaplan-Meier curves indicated a clinical benefit after three doses.

Conexiant